Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

“Anaplastic thyroid carcinoma is the most aggressive type of thyroid malignancies…”

 “These data suggest that CB2 overexpression may contribute to the regression of human anaplastic thyroid tumor… Given that cannabinoids have shown antitumor effects in many types of cancer models, CB2 may be a viable therapeutic target for the treatment of anaplastic thyroid carcinoma.”

http://www.ncbi.nlm.nih.gov/pubmed/18197164